Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05447156 · ClinicalTrials.gov registry record · NA
QuitGuide for American Indians: Aims 2 & 3
A NA study, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT05447156 is a NA study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 115 participants.
The verdict
NCT05447156, a NA study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
Aim 3: To test feasibility, acceptability, and preliminary efficacy of the tailored QuitGuide for smoking cessation among AIs.
Interventions
- BEHAVIORAL Tailored QuitGuide app
- BEHAVIORAL Standard QuitGuide app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2022-12-14 |
| Est. Completion | 2023-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05447156
The ClinicalTrials.gov registry entry for NCT05447156 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tailored QuitGuide app is the first listed.
NCT05447156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05447156 about?
NCT05447156 is a clinical study titled "QuitGuide for American Indians: Aims 2 & 3". Aim 3: To test feasibility, acceptability, and preliminary efficacy of the tailored QuitGuide for smoking cessation among AIs.
What is the current status of trial NCT05447156?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2022-12-14. Estimated completion is 2023-11-29.
What interventions are being tested in trial NCT05447156?
The interventions under investigation include: Tailored QuitGuide app (BEHAVIORAL), Standard QuitGuide app (BEHAVIORAL).
Who is sponsoring clinical trial NCT05447156?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.